Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphoma

European Journal of Cancer

Volumn 35, Issue 4, 1999, Pages 601-604

  Bower, M ^a   Fife, K ^a   Sullivan, A ^a   Kirk, S ^b   Phillips, R H ^a   Nelson, M ^a   Gazzard, B G ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

AIDS; HIV; Primary cerebral lymphoma

Indexed keywords

ANTIPROTOZOAL AGENT; ANTIRETROVIRUS AGENT; METHOTREXATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALGORITHM; ARTICLE; AUTOPSY; BRAIN BIOPSY; BRAIN LYMPHOMA; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; EPSTEIN BARR VIRUS; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0033119866     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00006-4     Document Type: Article

References (40)

1. Anders K., Guerra W., Tomiyasu U., et al. The neuropathology of AIDS: UCLA experience and review. Am. J. Pathol. 124:1986;537-558.
2. Moskowitz L., Hensley G., Chan J., et al. The neuropathology of acquired immune deficiency syndrome. Arch. Pathol. Lab. Med. 108:1984;867-872.
3. Ciricillo S., Rosenblum M. Use of CT and MRI imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J. Neurosurg. 73:1990;720-724.
4. Sadler M., Brink N., Gazzard B. Management of intracerebral lesions in patients with HIV: a retrospective study with discussion of diagnostic problems. Quarterly J. Med. 91:1998;205-217.
5. Levy R., Rosenbloom S., Perrett L. Neuroradiological findings in AIDS: a review of 200 cases. Am. J. Roentgenol. 147:1986;977-983.
6. Matthews C., Barba D., Fullerton S. Early biopsy versus empiric treatment with delayed biopsy of non-responders in suspected HIV-associated cerebral toxoplasmosis: a decision analysis. AIDS. 9:1995;1243-1250.
7. Clough L., Clough J., Maciunas R., Hass D. Diagnosing CNS mass lesions in patients with AIDS. The AIDS Reader. 7:1997;83-100.
8. DeAngelis L. Primary central nervous system lymphoma. Neurology. 41:1991;619-621.
9. Pedrol E., Gonzalez-Clemente J., Gatell J.M., et al. Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy. AIDS. 4:1990;511-517.
10. Carrazana E., Rossitch E., Samuels M. Cerebral toxoplasmosis in the acquired immune deficiency syndrome. Clin. Neurol. Neurosurg. 91:1989;291-299.
11. Cohn J., McMeeking A., Cohen W., et al. Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Am. J. Med. 86:1989;521-527.
12. MacMahon E., Glass J., Hayward S., et al. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet. 338:1991;969-973.
13. Cinque P., Brytting M., Vago L., et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet. 342:1993;398-401.
14. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
15. Peto R., Pike M., Armitage P., et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient II: analysis and examples. Br. J. Cancer. 35:1977;1-39.
16. Levine A. Acquired immunodeficiency syndrome-related lymphoma. Blood. 80:1992;8-20.
17. Donahue B., Sullivan J., Cooper J. Additional experience with empiric radiotherapy for presumed human immunodeficiency virus-associated primary central nervous system lymphoma. Cancer. 76:1995;328-332.
18. Baumagartner J., Rachlin J., Beckstead J., et al. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J. Neurosurg. 73:1990;206-211.
19. Formenti S., Gill P., Lean E., et al. Primary central nervous system lymphoma in AIDS. Results of radiation therapy. Cancer. 63:1989;1101-1107.
20. Corn B., Donahue B., Rosenstock J., et al. Performance status and age as independent predictors of survival among AIDS patients with primary CNS lymphoma: a multivariate analysis of a multi-institutional experience. Cancer J. Sci. Am. 3:1997;52-56.
21. Goldstein J., Dickson D., Moser F., et al. Primary central nervous system lymphoma in acquired immune deficiency syndrome. A clinical and pathologic study with results of treatment with radiation. Cancer. 67:1991;2756-2765.
22. Kaufmann T., Nisce L., Coleman M. A comparison of survival of patients treated for AIDS-related central nervous system lymphoma with and without tissue diagnosis. Int. J. Radiat. Oncol. Biol. Phys. 36:1996;429-432.
23. Fine H, Loeffler J. Primary central nervous system lymphoma. In Canellos G, Lister T, Sklar J, eds. The Lymphomas. Philadelphia, WB Saunders, 1998, 481-494.
24. Jacomet C., Girard P., Lebrette M., Farese V., Monfort L., Rozenbaum W. Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS. AIDS. 11:1997;1725-1730.
25. Schoondermark-van de Ven E., Galama J., Kraaijeveld C., et al. Value of the polymerase chain reaction for the detection of Toxoplasma gondii in cerebrospinal fluid from patients with AIDS. Clin. Infect. Dis. 16:1993;661-666.
26. Weber T., Turner R., Frye S., et al. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J. Infect. Dis. 169:1994;1138-1141.
27. Haas D. Current and future applications of polymerase chain reaction for Mycobacterium tuberculosis. Mayo. Clin. Proc. 71:1996;311-313.
28. Geddes J., Bhattacharjee M., Savage K., Scaravilli F., McLaughlin J. Primary cerebral lymphoma: a study of 47 cases probed for Epstein-Barr virus genome. J. Clin. Pathol. 45:1992;587-590.
29. Arribas J., Clifford D., Fichtenbaum C., Roberts R., Powderly W., Storch G. Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. J. Clin. Microbiol. 33:1995;1580-1583.
30. De Luca A., Antinori A., Cingolani A., et al. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br. J. Haematol. 90:1995;844-849.
31. Ruiz A., Ganz W., Post M., et al. Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from Toxoplasma encephalitis in AIDS patients. Am. J. Neuroradiol. 15:1994;1885-1894.
32. O'Malley J., Ziessman H., Kumar P., et al. Diagnosis of intracranial lymphoma in patients with AIDS: Value of 201 T1 single-photon emission computed tomography. Am. J. Roentgenol. 163:1994;417-421.
33. Pierce M., Johnson M., Maciunas R., et al. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann. Intern. Med. 123:1995;594-598.
34. Villringer K., Jager H., Dichgans M., et al. Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J. Comput. Assist. Tomogr. 19:1995;532-536.
35. Hoffman J., Waskin H., Schifter T., et al. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J. Nucl. Med. 34:1993;567-575.
36. Chang L., Miller B., McBride D., et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology. 197:1995;525-531.
37. Walot I., Miller B., Chang L., et al. Neuroimaging findings in patients with AIDS. Clinical Infect. Dis. 22:1996;906-919.
38. Antinori A., Ammassari A., De Luca A., et al. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology. 48:1997;687-694.
39. Cingolani A., De Luca A., Larocca L., et al. Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. J. Natl. Cancer Inst. 90:1998;364-369.
40. Castagna A., Cinque P., d'Amico A., Messa C., Fazsio F., Lazzarin A. Evaluation of contrast-enhancing brain lesions in AIDS patients by means of Epstein-Barr virus detection in cerebrospinal fluid and 201thallium single photon emission tomography. AIDS. 11:1997;1522-1523.